Results 141 to 150 of about 3,429 (181)
Experimental Physiology, Volume 111, Issue 8, Page 3502-3513, 1 August 2026.Abstract Standard chemotherapy regimens for patients with breast cancer are based on epirubicin–cyclophosphamide (EC) and paclitaxel (TAX) administrations. While it has been shown that first EC administration impairs mitochondrial homeostasis, the isolated effects of TAX have not been studied without previous chemotherapy exposure.
Joris Mallard +10 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
BioDrugs, 1999
Trastuzumab is a recombinant humanised monoclonal antibody specific for the growth factor receptor p185(HER2) (HER2) which is overexpressed in 25 to 30% of breast cancer tumours. The drug inhibits the growth of human breast cancer cells overexpressing HER2 in vitro and in vivo.
C M, Perry, L R, Wiseman
openaire +4 more sources
Trastuzumab is a recombinant humanised monoclonal antibody specific for the growth factor receptor p185(HER2) (HER2) which is overexpressed in 25 to 30% of breast cancer tumours. The drug inhibits the growth of human breast cancer cells overexpressing HER2 in vitro and in vivo.
C M, Perry, L R, Wiseman
openaire +4 more sources
Cancer Research, 2005
To the Editor: We read with interest the article by Adams et al. [(1)][1], which describes the efficacy of an yttrium-90-labeled anti-HER2 diabody in a mouse xenograft model of HER2-positive breast cancer.
Charles L, Vogel +2 more
openaire +2 more sources
To the Editor: We read with interest the article by Adams et al. [(1)][1], which describes the efficacy of an yttrium-90-labeled anti-HER2 diabody in a mouse xenograft model of HER2-positive breast cancer.
Charles L, Vogel +2 more
openaire +2 more sources